60
Hainan Huluwa Pharmaceutical Group Co., Ltd.
605199.SS · SHH
¥5.69 -0.52% (-¥0.03)
1M -6.39%
Market Cap ¥2.28B
P/E Ratio -
Div. Yield -
ROE 90.36%
Bulios Fair Price
¥6.04
6.2% upside
Current Price
¥5.69
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 605199.SS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
58 /100
Fair P/S 3.59x
P/B 7.61x
P/FCF 16.33x
Growth
0 /100
Declining Rev. growth 15.91%
Book val. growth 25.89%
EPS growth N/A
Profitability
33 /100
Weak Gross margin 14.76%
Net margin 63.59%
FCF margin 21.99%
Quality
3 /100
Poor ROIC 25.60%
ROE 90.36%
Asset turnover 0.26x
Debt
2 /100
High Debt/Equity 3.51x
Current ratio 0.51x
Int. coverage -11.29x
Stability
19 /100
Unstable Beta 0.33x
Rev. volatility 28.30%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 605199.SS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jing Ping Liu
Employees
2,103
Headquarters
Haikou